Drug Discovery News: CLCC joins $50m program targeting antibiotic resistance
Original article here Calla Lily joins $50M program targeting antibiotic resistance A new intravaginal drug delivery platform has been selected to investigate whether localized UTI treatment can reduce the collateral effects of systemic antibiotics. Written by Bree Foster, PhD Aug 11, 2026 New approaches aim to target infections while sparing the gut microbiome. credit: istock.com/Scharvik …
CLCC at the Microbes in Women’s Health Congress in Valencia
Our colleagues Andrew Lewis and Elham Shirani will be at the third Microbes in Women’s Health Congress in Valencia on 21-22 April. 🇪🇸 We’re excited to meet with existing and new partners for 2 days of talks, panels and networking. Our user convenient Callavid® drug delivery platform will help provide effective colonisation and epithelial adherence …
Amy Coulson joins the Vaginal Microbiome team
We’re delighted to welcome Amy Coulson to CLCC in advance of starting her Ph.D. journey at Queen Mary University of London. Over the next 4 years she’ll be working with our team and QMUL’s Centre for Doctoral Training in Next Generation Organ on a Chip Technology (COaCT) to develop a vaginal organ-on-a-chip to grasp successful …
Progress on Vaginal Microbiome R&D Lab
We had a highly productive all-day strategy session to discuss all things vaginal microbiome at , which included evaluating our very encouraging progress made in our specialised vaginal microbiome R&D lab. Very grateful for the world-class expertise from our esteemed advisors in this space: Dr David MacIntyre and Dr Janet Halliday. It’s been exciting to …
Funded PhD – Vaginal probiotics for reproductive health: microbiome organ-chip
Calla Lily Clinical Care is delighted to partner with Queen Mary University for this fully funded (incl student stipend) four-year PhD starting September 2025 as part of the EPSRC Centre for Doctoral Training in Next Generation Organ on a Chip Technology (COaCT) cohort training programme. The COaCT is a 4-year PhD cohort training programme, co-delivered with key …
The Importance of Vaginal Health— Why It Matters for Every Woman
Let’s be blunt—vaginal health isn’t a subject many are comfortable talking about (even in the U.S. and Europe). Let’s also not forget I have an 11-year old male child who routinely asks me to “stop talking dirty” when I’m on a work call. It’s also an issue for a lot of investors who don’t want …
Funded MSc + PhD Studentship: Delivery of live biotherapeutics for restoration of women’s reproductive health
Calla Lily Clinical Care is delighted to partner with the University of Warwick for this fully funded (incl student stipend) four-year iCASE studentship from September 2025, available as part of Warwick’s MRC-funded Doctoral Training Partnership (DTP). Vaginal microbiota play a key role in women’s reproductive health. Disruption of the normal vaginal microbiome is associated with inflammation …
“Unlocking the Potential of the Vaginal Microbiome” panel at WHIS Boston
Our Co-Founder Dr Lara Zibners will be at the Women’s Health Innovation USA 2024 summit in Boston to talk about the exciting vaginal microbiome space as part of the panel “Unlocking the Potential of the Vaginal Microbiome”. The advancing science is becoming impossible to ignore: reproductive tract dysbiosis or the lack of a healthy vaginal …
Attending the Inaugral Microbes in Women’s Health Congress
Our Principal Scientist Andrew Lewis and Co-Founder Thang Vo-Ta recently took part in the inaugural Microbes in Women’s Health Congress in Copenhagen! They attended superb seminars/presentations, had great catch-ups and forged new & important connections in the groundbreaking microbiome space. The unfolding science is getting undeniable: reproductive tract dysbiosis or the lack of a healthy …